What Anika Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 2 | 4 |
| Sells | 0 | 0 |
| Total trades | 2 | 35 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 2,000 | 233,243 |
| Disposed | 0 | 53,265 |
| Net activity | +2,000 | +179,978 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Fishetti Gary P | Director | Aug 04 | Open-market buy · P | +1,000 | $20.32 | +$20.3K | 54,015 |
| Fishetti Gary P | Director | Aug 03 | Open-market buy · P | +1,000 | $20.75 | +$20.7K | 53,015 |
| Capper Joseph H | Director | Jun 18 | Grant / award · A | +10,402 | — | — | 30,805 |
| Conley Sheryl L | Director | Jun 18 | Grant / award · A | +10,402 | — | — | 52,970 |
| Richard Stephen | Director | Jun 18 | Grant / award · A | +10,402 | — | — | 58,273 |
| Henneman John B Iii | Director | Jun 18 | Grant / award · A | +10,402 | — | — | 65,273 |
| Fishetti Gary P | Director | Jun 18 | Grant / award · A | +10,402 | — | — | 52,015 |
| Griffin Stephen D. | President and CEO | Jun 03 | Withheld — tax / exercise cost · F | −3,769 | $14.41 | −$54.3K | 45,973 |
| Griffin Stephen D. | President and CEO | Jun 03 | Exercise / conversion · M | +12,840 | — | — | 49,742 |
| Henneman John B Iii | Director | May 01 | Open-market buy · P | +5,000 | $14.66 | +$73.3K | 54,871 |
| Griffin Stephen D. | President and CEO | Apr 30 | Open-market buy · P | +12,200 | $12.29 | +$150K | 36,163 |
| McLeod Ian | SVP, CAO & Treasurer | Mar 15 | Withheld — tax / exercise cost · F | −781 | $14.20 | −$11.1K | 24,107 |
| McLeod Ian | SVP, CAO & Treasurer | Mar 15 | Exercise / conversion · M | +2,658 | — | — | 24,888 |
| Colleran David | EVP, General Counsel, Corp Sec | Mar 15 | Withheld — tax / exercise cost · F | −1,893 | $14.20 | −$26.9K | 67,570 |
| Colleran David | EVP, General Counsel, Corp Sec | Mar 15 | Exercise / conversion · M | +6,449 | — | — | 69,463 |
| Blanchard Cheryl R | Director | Mar 15 | Withheld — tax / exercise cost · F | −12,104 | $14.20 | −$172K | 258,788 |
| Blanchard Cheryl R | Director | Mar 15 | Exercise / conversion · M | +25,131 | — | — | 270,892 |
| McLeod Ian | SVP, CAO & Treasurer | Mar 14 | Withheld — tax / exercise cost · F | −1,449 | $14.20 | −$20.6K | 22,230 |
| McLeod Ian | SVP, CAO & Treasurer | Mar 14 | Grant / award · A | +1,161 | — | — | 23,679 |
| McLeod Ian | SVP, CAO & Treasurer | Mar 14 | Exercise / conversion · M | +3,774 | — | — | 22,518 |
Loading...
